Moody's Investors Service ("Moody's") announced today that the execution of the First Amendment to Financing Agreement, effective as of May 5, 2023 (the "First Amendment"), among Entrinsic Bioscience, LLC (the "Company"), Entrinsic Intermediate Holdings, LLC (together with the Company, the "Borrowe...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.